Instituto Nacional de Ciencias Medicas de Nutricion Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2010
NCT01135628
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

lactobacillus reuteri (1 trial)

nitazoxanide (alinia) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2